Search Results
Oct 21, 2025, 08:30 ET Halozyme to Report Third Quarter 2025 Financial and Operating Results
goal of improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. Having touched one million patient lives in post-marketing use in ten commercialized products in at least one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE®
More news about: Halozyme Therapeutics, Inc.
Oct 21, 2025, 08:30 ET Talphera Announces the Appointment of Joe Todisco to Board of Directors
tolerate heparin or are at risk for bleeding. The primary endpoint of the study is mean post-filter activated clotting time using Niyad versus placebo over the first 24 hours. Key secondary endpoints include the mean post-filter activated clotting time over 72 hours, filter lifespan, number of filter changes
More news about: Talphera, Inc.
Oct 21, 2025, 08:30 ET Revalesio to Present RNS60 <12-Hour Data from the Phase 2 RESCUE Trial in Acute Ischemic Stroke at World Stroke Congress 2025
Revalesio, a clinical-stage pharmaceutical company pioneering neuroprotective therapies for neurological disorders, today announced that data from a post hoc analysis of the RESCUE Phase 2 clinical trial of its investigational drug RNS60 will be featured as one of two promising drug candidates for the
More news about: Revalesio Corporation
Oct 21, 2025, 08:18 ET aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman
Friday, September 12, cratered to close at just $1.02 per share on September 15—a catastrophic one-day decline of 83.2%. In its post-announcement comments, the company stated that it would engage with the Food and Drug Administration (FDA) to determine a path forward, acknowledging
More news about: Hagens Berman Sobol Shapiro LLP
Oct 21, 2025, 08:08 ET Newly Released Clinical Study Suggests That Neurostimulation Device May Reduce Both Opioid and Stimulant Use, Offering Hope Amid Nation's Addiction Crisis
of addiction. Patients who self-administered NET Device™ stimulation for at least one day stayed longer in the residential program and reported fewer post-discharge days of drug use overall over 3 months. These outcomes could be early indicators of longer-term recovery. While the device is cleared by the
More news about: NET Recovery
Oct 21, 2025, 08:00 ET Onkos Surgical® Receives FDA 510(k) Clearance for ELEOS™ Proximal Tibia with NanoCept® Antibacterial Technology
reconstruction options for patients with significant bone loss due to cancer, trauma, or previous surgical procedures. "This first post-De Novo 510(k) clearance marks a major milestone, highlighting our commitment and capability to advance NanoCept technology throughout the ELEOS implant
More news about: ONKOS SURGICAL
Oct 21, 2025, 08:00 ET Flexsys Earns EcoVadis Platinum Rating and Validates Ambitious Science-Based Targets, Reinforcing Its Commitment to a Net-Zero, Sustainable Tire Industry
sustainability of rubber products. Its portfolio includes innovations such as Crystex™ vulcanizing agents, Santoflex™ antidegradants, and Duralink™ HTS post-vulcanization stabilizers. Operating across four continents with eight manufacturing facilities and two technology centers, Flexsys continues to pioneer
More news about: Flexsys
Oct 21, 2025, 08:00 ET Flexsys Earns EcoVadis Platinum Rating and Validates Ambitious Science-Based Targets, Reinforcing Its Commitment to a Net-Zero, Sustainable Tire Industry
sustainability of rubber products. Its portfolio includes innovations such as Crystex™ vulcanizing agents, Santoflex™ antidegradants, and Duralink™ HTS post-vulcanization stabilizers. Operating across four continents with eight manufacturing facilities and two technology centers, Flexsys continues to pioneer
More news about: Flexsys
Oct 21, 2025, 08:00 ET Rollick Expands Reach into New Industry Segments
industries. Utilized by over 150 OEMs and more than 4,000 dealers, Rollick's SaaS solutions encompass enterprise lead management, digital retailing, post-sale customer experience, and marketing automation. In addition, the company has rapidly built its outdoor recreational vehicle buying marketplace,
More news about: Rollick, Inc.
Oct 21, 2025, 08:00 ET Holiday Tradition Continues: BofA "More Rewards Day" Bonuses Approaching $100 Million
not considered retail purchases and do not apply for purposes of this offer. Generally, we expect to process bonuses on rewards cards as transactions post to the account, and within 20 days of transactions posting for non-rewards cards, but for certain transactions and merchants, it may take longer. Therefore,
More news about: Bank of America Corporation
Oct 21, 2025, 08:00 ET Breakthrough clinical trial confirms that GammaTile delivers superior tumor control compared to standard of care for patients with newly diagnosed operable brain metastases
disease. Neuro-Oncology. 2021;23(9):1447-1456. Mahajan A, Ahmed S, McAleer MF, et al. Prospective randomized trial of post-operative stereotactic radiosurgery versus observation for completely resected brain metastases. Lancet Oncol. 2017;18(8):1040-1048.
More news about: GT Medical Technologies
Oct 21, 2025, 07:45 ET Jacobs to Hold Its Fiscal Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast
following to comply with our disclosure obligations under Regulation FD: press releases, SEC filings, public conference calls, or our website. We routinely post important information on our website at www.jacobs.com, including information that may be deemed
More news about: Jacobs
Oct 21, 2025, 07:30 ET Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
first-to-world smart knee implant that captures patient-specific gait and range of motion metrics directly from the knee during patient monitoring to provide post-operative recovery insights10,11 and trends, allowing care teams to monitor and personalize the TKA patient experience.10-12
More news about: Zimmer Biomet Holdings, Inc.
Oct 21, 2025, 06:55 ET Genuine Parts Company Reports Third Quarter 2025 Results and Updates Full-Year Outlook
Pension and other post–retirement benefit liabilities
More news about: Genuine Parts Company
Oct 21, 2025, 06:30 ET Equifax Delivers Results Above Third Quarter Guidance; Raising Full Year Guidance
billion share repurchase program. Our ability to deliver significant excess free cash flow to shareholders is a big milestone for Equifax as we move post-Cloud to fully focus on growth, innovation, new products, and free cash generation to continue investing in EFX for growth and return cash to shareholders.
More news about: Equifax Inc.
Oct 21, 2025, 06:26 ET GoNoodle and Wounded Warrior Project Bring Veterans Day Learning to Classrooms Nationwide
Wounded Warrior Project is our nation's leading veteran services organization, focused on the total well-being of post-9/11 wounded, ill, or injured veterans. Our programs, advocacy, and awareness efforts help warriors thrive, provide essential lifelines to families
More news about: GoNoodle
Oct 21, 2025, 06:00 ET Learning Heroes Releases New Report: Centering Families in the Future of Education
outlines strategies such as clearer home-school communications and stronger supports for those navigating learning differences or exploring alternative post-secondary pathways. Here are 10 insights that the report surfaces, at a glance:
More news about: Learning Heroes
Oct 21, 2025, 03:32 ET Insider information: Anssi Huhta appointed as new CEO of Aktia Bank Plc
Directors has appointed Anssi Huhta as the new CEO of the company. Huhta has served as Aktia's interim CEO since 12 June 2025 and he will take up his post immediately. Anssi Huhta has worked at Aktia and been a member of the company's Executive Committee since 2020, first as EVP,
More news about: Aktia Bank
Oct 21, 2025, 03:30 ET MTC Namibia selects VOX Solutions as its exclusive international gateway for A2P SMS and Voice traffic
Namibia: MTC (Mobile Telecommunications Limited) was established in 1995 as a joint venture between Namibia Post and Telecommunications Holdings (NPTH), Telia and Swedfund. During May 2004, NPTH concluded a deal that saw it hold 100 per cent of the shares in MTC
More news about: Vox Solutions
Oct 21, 2025, 03:15 ET Wondershare Launches the ToMoviee AI Spooktacular Video Challenge, Empowering Global Creators to Redefine Halloween Storytelling with AI
Create: Produce an original Halloween-themed short video (15–60 seconds) using ToMoviee AI. Publish: Post the video publicly on platforms such as YouTube, TikTok, or Instagram. Tag: Include the hashtags
More news about: Wondershare Technology
Oct 20, 2025, 22:49 ET Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy
Oct. 20, 2025 /PRNewswire/ -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a major breakthrough by the tech giant's biological artificial intelligence (AI) system.
More news about: Senhwa Biosciences, Inc.
Oct 20, 2025, 20:22 ET Export Finance Australia issues Conditional Letter of Support for the Donald Project
FID and A$138 million is expected to be contributed post-FID, providing capital for pre-development and construction activities. Pro-rata equity contributions by the joint venturers on a 51%/49% basis amounting to additional post-FID contributions of A$122 million (of which Astron's
More news about: Energy Fuels Inc.
Oct 20, 2025, 19:04 ET Whirlpool Corporation Declares Quarterly Dividend
WhirlpoolCorp.com. Website DisclosureWe routinely post important information for investors on our website, whirlpoolcorp.com, in the "Investors" section. We also intend to update the Hot Topics Q&A portion
More news about: Whirlpool Corporation
Oct 20, 2025, 18:17 ET Pheromones, Bee Venom, and Tattoo Cover-Ups: Market Defense's Prime Big Deal Days 2025 Report Reveals Beauty's Most Unexpected Trends
Market Defense, added: "As these tentpole events become more competitive with rising CPCs, brands will need to be more creative with a solid plan post-event to keep momentum going, retarget audiences and take advantage of when others pull back." Karan Raturi,
More news about: Market Defense LLC
Oct 20, 2025, 17:46 ET ManaMed® Secures FDA 510(k) Clearance for PlasmaFlow® X -- a Breakthrough, Compact Sequential Compression System with All-Day Battery
aiding in DVT prevention, can be used as an aid in the prophylaxis for DVT by persons expecting to be stationary for long periods of time, diminish post-operative pain and swelling, and enhancing blood circulation. The device features preset compression and a streamlined, tubeless configuration to support
More news about: ManaMed LLC